rewirebio.iobenchmarks
Pipeline

CIViC fixed-schema evidence retrieval evaluation workflow

Published fixed-triplet evidence-direction workflow with tool-assisted and unaided configurations; no clinical validation claim.

3 evaluations · 162 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for CIViC fixed-schema evidence retrieval evaluation workflow. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluations and results

3 evaluations · 162 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.83 Accuracy
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP: integrating large language models with the Clinical Interpretations of Variants in Cancer · Fig1c Overall Accuracy; Section 3
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.84 Micro F1 (evidence type: diagnostic)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP: integrating large language models with the Clinical Interpretations of Variants in Cancer · Figure 1c, diagnostic row, agent column
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0 F1 (class: diagnostic negative)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Negative, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0 Precision (class: diagnostic negative)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Negative, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0 Recall (class: diagnostic negative)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Negative, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.94 F1 (class: diagnostic positive)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Positive, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.89 Precision (class: diagnostic positive)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Positive, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Recall (class: diagnostic positive)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Diagnostic / Positive, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 F1 (class: functional dominant negative)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Dominant Negative, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Precision (class: functional dominant negative)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Dominant Negative, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Recall (class: functional dominant negative)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Dominant Negative, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.88 Micro F1 (evidence type: functional)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP: integrating large language models with the Clinical Interpretations of Variants in Cancer · Figure 1c, functional row, agent column
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.67 F1 (class: functional gain of function)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Gain of Function, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.75 Precision (class: functional gain of function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Gain of Function, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.6 Recall (class: functional gain of function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Gain of Function, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.92 F1 (class: functional loss of function)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Loss of Function, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.86 Precision (class: functional loss of function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Loss of Function, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Recall (class: functional loss of function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Loss of Function, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 F1 (class: functional unaltered function)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Unaltered Function, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Precision (class: functional unaltered function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Unaltered Function, precision
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
1 Recall (class: functional unaltered function)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Functional / Unaltered Function, recall
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.91 Micro F1
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP: integrating large language models with the Clinical Interpretations of Variants in Cancer · Fig1c Micro F1; Section 3
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.96 Micro F1 (evidence type: oncogenic)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP: integrating large language models with the Clinical Interpretations of Variants in Cancer · Figure 1c, oncogenic row, agent column
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.96 F1 (class: oncogenic oncogenicity)
unitless · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Oncogenic / Oncogenicity, f1
Configuration: ChatGPT Agent Mode, 2–7 March 2026 CIViC evaluationProtocol: CIViC evidence-direction retrieval, March 2026
Dataset: CIViC 100 molecular-profile/disease/therapy triplets, March 2026
0.92 Precision (class: oncogenic oncogenicity)
fraction · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CIViC agent retrieval

Not reported

Aggregation: Not reported

CIViC MCP supplementary methods and complete Tables 1–3 · Supplementary Table 3, Oncogenic / Oncogenicity, precision

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this pipeline

How it works, versions and access

Versions and evaluated configurations

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-pipeline-civic-retrieval.

Source locator: Supplementary implementation and Agent Mode evaluation methods

Related records

How to cite

CIViC fixed-schema evidence retrieval evaluation workflow. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/pipeline/uc-clinical-20260930-pipeline-civic-retrieval/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction